The Evaluation of the Combination of Caspofungin with Voriconazole and Amphotericin B against Clinical Candida krusei Isolates by Etest and Disk Diffusion Methods

References (31)

1. 1 Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test [DOI]
2. 2 Method for antifungal disk diffusion susceptibility testing of yeasts : Approved guideline
3. 3 The changing epidemiology of invasive candidiasis [DOI]
4. 4 Candida krusei , a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005 [DOI]
5. 5 Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints [DOI]
6. 6 Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints [DOI]
7. 7 Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species [DOI]
8. 8 Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme [DOI]
9. 9 Combination and Sequential Antifungal Therapy for Invasive Aspergillosis: Review of Published In Vitro and In Vivo Interactions and 6281 Clinical Cases from 1966 to 2001 [DOI]
10. 10 Combinations of antifungal agents in therapy–what value are they? [DOI]
11. 11 Comparative Evaluation of Etest and Sensititre YeastOne Panels against the Clinical and Laboratory Standards Institute M27-A2 Reference Broth Microdilution Method for Testing Candida Susceptibility to Seven Antifungal Agents [DOI]
12. 12 Trends in antifungal susceptibility testing using CLSI reference and commercial methods [DOI]
13. 13 In Vitro Evaluation of Double and Triple Combinations of Antifungal Drugs against Aspergillus fumigatus and Aspergillus terreus [DOI]
14. 14 In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest [DOI]
15. 15 Comparison of In Vitro Susceptibility Characteristics of Candida Species from Cases of Invasive Candidiasis in Solid Organ and Stem Cell Transplant Recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006 [DOI]
16. 16 Correlation of Neo-Sensitabs Tablet Diffusion Assay Results on Three Different Agar Media with CLSI Broth Microdilution M27-A2 and Disk Diffusion M44-A Results for Testing Susceptibilities of Candida spp. and Cryptococcus neoformans to Amphotericin B, Caspofungin, Fluconazole, Itraconazole, and Voriconazole [DOI]
17. 17 Amphotericin B- and Voriconazole-Echinocandin Combinations against Aspergillus spp.: Effect of Serum on Inhibitory and Fungicidal Interactions [DOI]
18. 18 Interlaboratory Reproducibility of Etest Amphotericin B and Caspofungin Yeast Susceptibility Testing and Comparison with the CLSI Method [DOI]
19. 19 Comparison of Results of Voriconazole Disk Diffusion Testing for Candida Species with Results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program [DOI]
20. 20 Efficacy of Caspofungin and Voriconazole Combinations in Experimental Aspergillosis [DOI]
21. 21 Rates and Extents of Antifungal Activities of Amphotericin B, Flucytosine, Fluconazole, and Voriconazole against Candida lusitaniae Determined by Microdilution, Etest, and Time-Kill Methods [DOI]
22. 22 Evaluation of Etest Method for Determining Fluconazole and Voriconazole MICs for 279 Clinical Isolates of Candida Species Infrequently Isolated from Blood [DOI]
23. 23 Comparative Evaluation of the Vitek 2 Yeast Susceptibility Test and CLSI Broth Microdilution Reference Method for Testing Antifungal Susceptibility of Invasive Fungal Isolates in Italy: the GISIA3 Study [DOI]
24. 24 Blood Stream Infections by Candida glabrata and Candida krusei: A Single-Center Experience [DOI]
25. 25 In Vitro Activities of Echinocandins againstCandida kruseiDetermined by Three Methods: MIC and Minimal Fungicidal Concentration Measurements and Time-Kill Studies [DOI]
26. 26 Correlation between Etest®, disk diffusion, and microdilution methods for antifungal susceptibility testing of Candida species from infection and colonization [DOI]
27. 27 In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii [DOI]
28. 28 Synergistic Activities of Three Triazoles with Caspofungin against Candida glabrata Isolates Determined by Time-Kill, Etest, and Disk Diffusion Methods [DOI]
29. 29 Anticandidal effects of voriconazole and caspofungin, singly and in combination, against Candida glabrata, extracellularly and intracellularly in granulocyte-macrophage colony stimulating factor (GM-CSF)-activated human monocytes [DOI]
30. 30 Caspofungin in Combination with Amphotericin B against Candida parapsilosis [DOI]
31. 31 Species distribution andin vitroantifungal susceptibility of clinicalCandidaisolates from a university hospital in Turkey over a 5-year period [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• Phytochemical Profile, Acute Toxicity, and Fluconazole-modulating Antifungal Activity of Stem and Barck Extracts of Adansonia digitata L. (Bombacaceae) against Nakaseomyces glabratus Isolates in Côte d’Ivoire — shares topic coverage
• Efficient In vitro Micro Propagation of Andrographis paniculata and Evaluation of Antibacterial Activity from Its Crude Protein Extract — shares topic coverage
• In vitro Antibacterial Activity of Cichorium intybus against some Pathogenic Bacteria — shares topic coverage
• Diagnosis of Fungi Contaminating Local and Imported Fruits in Kirkuk Using PCR — shares topic coverage